| Terumo expands global presence with new subsidiary in South-Africa | https://www.terumo-europe.com/en-emea/news/terumo-expands-global-presence-with-new-subsidiary-in-south-africa | Terumo expands global presence with new subsidiary in South-Africa | | 11/29/2023 11:00:00 PM | <p>Terumo Corporation (TSE: 4543) today announced the establishment of Terumo South Africa (Pty) Ltd. (Terumo South Africa), its newest subsidiary in South-Africa. This strategic move represents a significant milestone in the company’s continued commitment to expanding its global footprint and strengthening its presence in key growing markets.<br></p> |
| ANGIO-SEAL™ VIP & FEMOSEAL™ VASCULAR CLOSURE DEVICES SECURED CE CERTIFICATE UNDER THE NEW MEDICAL DEVICE REGULATION | https://www.terumo-europe.com/en-emea/news/angio-seal™-vip-femoseal™-vascular-closure-devices-secured-ce-certificate-under-the-new-medical-device-regulation | ANGIO-SEAL™ VIP & FEMOSEAL™ VASCULAR CLOSURE DEVICES SECURED CE CERTIFICATE UNDER THE NEW MEDICAL DEVICE REGULATION | | 10/3/2023 10:00:00 PM | <p>Terumo (TSE: 4543) is proud to announce that both of our Vascular Closure Devices, Angio-Seal™ VIP & Femoseal™, received the EU MDR certifications.<br></p> |
| Terumo Group Associates Celebrate Terumo Patient’s Day 2023 | https://www.terumo-europe.com/en-emea/terumo-group-associates-celebrate-terumo-patient’s-day-2023 | Terumo Group Associates Celebrate Terumo Patient’s Day 2023 | | 9/14/2023 10:00:00 PM | <p>Terumo Corporation (TSE: 4543) today held “Terumo Patient’s Day 2023” to connect with Terumo’s Group Mission of “Contributing to Society through Healthcare”, and for each associate to reconfirm their day-to-day contribution at work ultimately leads to the well-being of patients.<br></p> |
| Terumo to Construct a New Manufacturing Facility at its Kofu Factory for the Medical Care Solutions Company | https://www.terumo-europe.com/en-emea/news/terumo-to-construct-a-new-manufacturing-facility-at-its-kofu-factory-for-the-medical-care-solutions-company | Terumo to Construct a New Manufacturing Facility at its Kofu Factory for the Medical Care Solutions Company | | 5/14/2023 10:00:00 PM | <p>52.2 Billion JPY Capital Investment to Strengthen the Production Capability to Meet the Growing Global Demands<br></p> |
| Ultimaster Nagomi™ MDR certification and launch of large-scale post-market study investigating the new coronary stent system in complex PCI | https://www.terumo-europe.com/en-emea/news/ultimaster-nagomi™-mdr-certification-and-launch-of-large-scale-post-market-study-investigating-the-new-coronary-stent-syste | Ultimaster Nagomi™ MDR certification and launch of large-scale post-market study investigating the new coronary stent system in complex PCI | | 4/25/2023 10:00:00 PM | <p></p>First patient enrolled in the NAGOMI COMPLEX PMCF study <br> |
| Terumo Group’s Targets for Greenhouse Gas Reduction Approved by the SBT Initiative as 1.5°C Aligned | https://www.terumo-europe.com/en-emea/news/terumo-group’s-targets-for-greenhouse-gas-reduction-approved-by-the-sbt-initiative-as-1-5°c-aligned | Terumo Group’s Targets for Greenhouse Gas Reduction Approved by the SBT Initiative as 1.5°C Aligned | | 4/23/2023 10:00:00 PM | <p>Terumo Corporation (TSE: 4543) today announced that its greenhouse gas (GHG) emissions reduction targets have been approved by the Science Based Targets initiative (SBTi) as being aligned with the common goal to limit global temperature rise to 1.5°C above pre-industrial levels.<br></p> |
